Day: April 3, 2020

AS VALMIERAS STIKLA ŠĶIEDRA (Registration No.: 40003031676, legal address: Cempu iela 13, Valmiera, LV-4201) (hereinafter – the Company) would like to announce that due to several influencing circumstances the amendments to the plan of the legal protection process (hereinafter – the Plan) have been made. The amendments are introduced with an aim to ensure the sustainable economic activities of the Company and to promote a stable cash flow, which is a precondition to enable the Company to settle accounts in full with all the creditors of the Plan.The Company indicates the most significant amendments included in the Plan:The principal payments for secured creditors of the fourth and fifth month are postponed until October 31, 2021. Within the term of implementation of the Plan the Company continues to pay compensation for the restriction...

AS VALMIERAS STIKLA ŠĶIEDRA (reģistrācijas Nr.: 40003031676, juridiskā adrese: Cempu ielā 13, Valmierā, LV-4201) (turpmāk – “Sabiedrība”) informē, ka vairāku ietekmējošu apstākļu dēļ veikti grozījumi tiesiskās aizsardzības procesa plānā (turpmāk – “Plāns”). Grozījumi Plānā tiek veikti ar mērķi nodrošināt sabiedrības ilgtspējīgu saimniecisko darbību, kā arī veicināt stabilu naudas plūsmu, kas ir priekšnosacījums tam, lai Sabiedrība varētu pilnībā norēķināties ar visiem kreditoriem.Sabiedrība norāda būtiskākos Plānā ietvertos grozījumus:Plānā 4. un 5. mēnesī paredzētie pamatsummas maksājumi nodrošinātājiem kreditoriem atlikti uz laiku līdz 2021. gada 31. oktobrim. TAP īstenošanas laikā Sabiedrībā maksā atlīdzību par nodrošināto kreditoru tiesību ierobežošanu TAP laikā, kā arī komisijas maksu par spēkā esošo galvojumu izmantošanu.Sabiedrība...

Norwegian Hydrogen AS, founded by Flakk Group and lead partner of the Hellesylt Hydrogen Hub consortium has successfully raised NOK 10.3 million in a capital increase.The Hellesylt Hydrogen Hub, a consortium of leading players in the hydrogen field, including Hexagon will focus on the development of a hydrogen production facility that can deliver hydrogen to ferries and cruise ships in the Geirangerfjord, as well as to other mobility applications. The ambition is to achieve zero emission operations in the Geirangerfjord, one of two World Heritage Fjords in Norway, by producing green hydrogen locally.See attached press release by Flakk Group for more information.For more information:Karen Romer, SVP Communications, Hexagon Composites ASATelephone: +47 950 74 950 | Karen.Romer@hexagongroup.com About Hexagon CompositesHexagon delivers safe...

Privanet Group OyjYHTIÖTIEDOTE03.04.2020 kello 17.30Privanet Group Oyj:n varsinaisen yhtiökokouksen päätökset ja hallituksen järjestäytyminenPrivanet Group Oyj:n 3.4.2020 pidetty varsinainen yhtiökokous:vahvisti tilinpäätöksen ja konsernitilinpäätöksen 31.12.2019 päättyneeltä tilikaudeltapäätti, että 31.12.2019 päättyneeltä tilikaudelta vahvistettavan taseen perusteella ei jaeta osinkoapäätti myöntää vastuuvapauden 31.12.2019 päättyneeltä tilikaudelta yhtiön hallituksen jäsenille sekä toimitusjohtajallepäätti yhtiön hallituksen jäsenille seuraavan varsinaisen yhtiökokouksen päättymiseen saakka maksettavista palkkioistapäätti valita yhtiön hallitukseen neljä jäsentäpäätti valita yhtiön hallitukseen jäseniksi nykyiset hallituksen jäsenet Mika Lehtimäki ja Kim Wiio uudelleen toimikaudelle, joka jatkuu seuraavan varsinaisen yhtiökokouksen...

MELVILLE, N.Y., April 03, 2020 (GLOBE NEWSWIRE) — Data Storage Corporation (OTCQB:DTST) (“DSC” and the “Company”), a provider of diverse business continuity, disaster recovery protection and cloud solutions, has launched a new remote collaboration offering for small and medium-sized businesses.The program transitions companies from static central offices to a dynamic remote worker environment, improving communications and allowing seamless collaboration.  The goal of the program is to allow employees to work from anywhere without boundaries.  The program starts with consulting services, whereby DSC analyzes its client’s needs to determine areas that need attention—from internet and private data circuits to collaboration tools, including video conferencing and web-based calls.  As part of the new program, DSC is offering free migration...

– Contract for up to $14.3 million for 15,325 Courses –NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the Canadian Department of National Defence (CDND) has awarded a contract to Meridian Medical Technologies, Inc. (“Meridian”, a Pfizer Company) (Canadian Contract), in which it will purchase up to 15,325 courses of oral TPOXX (tecovirimat) over four years for a total value of $14.3 million, with an initial purchase of 2,500 courses for $2.3 million. “The current COVID-19 pandemic has reminded us all that preparedness with medical countermeasures is critical for responding effectively to any infectious disease outbreak,” said Dr. Phil Gomez, CEO of SIGA Technologies. “Smallpox...

MONTREAL, April 03, 2020 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore” or the “Corporation”) (TSX-V: GRA) is pleased to announce the completion of the previously announced “bought deal” private placement for total gross proceeds of $25,000,040 (the “Offering”). The Offering was conducted by a syndicate of underwriters led by Echelon Wealth Partners Inc., and including Paradigm Capital Inc., Stifel Nicolaus Canada Inc., Raymond James Ltd., National Bank Financial Inc., Beacon Securities Limited and Cormark Securities Inc. (collectively the “Underwriters”). In connection with the Offering, the Corporation paid the Underwriters a cash commission equal to 5% of the gross proceeds of the Offering, other than in respect of Common Shares subscribed by certain investors’ (the President’s List), in which case the Underwriters...

MONTRÉAL, 03 avr. 2020 (GLOBE NEWSWIRE) — NanoXplore Inc. (TSX-V : GRA) (« NanoXplore » ou la « Société ») est heureuse d’annoncer la réalisation du placement privé par prise ferme annoncé précédemment, pour un produit brut total de 25 000 040 $ (le « Placement »). Le Placement a été mené par un syndicat de preneurs fermes dirigé par Echelon Wealth Partners Inc., et incluant Paradigm Capital Inc., Stifel Nicolaus Canada Inc., Raymond James Ltd., Financière Banque Nationale Inc., Beacon Securities Limited et Cormark Securities Inc. (collectivementles « Preneurs fermes »). Dans le cadre du Placement, la Société a versé aux Preneurs fermes une commission en espèces correspondant à 5% du produit brut du Placement, sauf à l’égard des Actions ordinaires souscrites par certains investisseurs (la liste du président), auquel...

idi   INVESTIR EN PRIVATE EQUITYNombre total de droits de vote et d’actionscomposant le capital social au 31 mars 2020(Article L. 233-8 II du Code de Commerceet les articles 221-1 et 223-16 du Règlement Général de l’AMF)Paris, le 3 avril 2020 – Au 31 mars 2020 le capital de l’IDI s’établit comme suit :* Nombre total de droits de vote attachés aux actions – actions privées du droit de voteContact investisseurs :Tatiana NourissatTél. : + 33 1 55 27 80 00E-mail : t.nourissat@idi.frGroupe IDI – 18, avenue Matignon 75008 PARIS – +33 1 55 27 80 00 – www.idi.fr – communications@idi.fr   Pièce jointeDroit de votes

NEW YORK and SYDNEY, Australia, April 03, 2020 (GLOBE NEWSWIRE) — Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, is pleased to announce it has been added to the list of Commercial Manufacturers and Laboratories which have notified the U.S. Food and Drug Administration (FDA) that they have validated serology tests as set forth in Section IV.D of the FDA’s Policy for Diagnostic Tests for Coronavirus Disease – 2019 (“the Policy”).Under this Policy, the FDA does not intend to object to the development and distribution by commercial manufacturers, or development and use by laboratories, of serology tests to identify antibodies to...